{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:14:05Z","timestamp":1787026445484,"version":"build-2736575974"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to investigate the association between serum 25-hydroxyvitamin D3 (25(OH)D3) levels and cognitive impairment (CI) in middle-aged and elderly individuals with type 2 diabetes mellitus (T2DM). Additionally, we sought to evaluate the potential of serum 25(OH)D3 as a marker associated with CI and to identify relevant influencing factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study included 221 middle-aged and elderly patients with T2DM, aged 50\u201380 years. Participants were divided into a group without cognitive impairment (n = 131, 59.28%) and a group with cognitive impairment (n = 90, 40.72%) based on cognitive function status. Demographic characteristics, clinical indicators (e.g., age, disease duration, body composition, comorbidities), and laboratory test results (e.g., 25(OH)D3, fasting C-peptide, fasting insulin, blood lipids) were collected. Logistic regression analysis was used to examine the association between 25(OH)D3 and cognitive impairment. Analyses included univariate logistic regression, multivariate regression adjusted for three sets of confounders, subgroup analyses, interaction tests, and ROC curve analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The two groups showed statistically significant differences in age, disease duration, fasting C-peptide, fasting insulin, cholesterol, serum 25(OH)D3 levels, and 25(OH)D3 quartile distribution (P &amp;lt; 0.05). Differences in other indicators were not statistically significant (P &amp;gt; 0.05). Logistic regression analysis revealed that higher serum 25(OH)D3 levels were significantly associated with a lower prevalence of cognitive impairment. This association remained robust after adjusting for multiple confounders (including gender, hypertension, cerebral infarction, and coronary heart disease) in Model 3 (OR\u00a0=\u00a00.92, 95% CI: 0.88\u20130.97, P &amp;lt; 0.001). In the 25(OH)D3 quartile subgroup analysis, compared with the Q1 group, the Q3 (OR\u00a0=\u00a00.35, P\u00a0=\u00a00.034) and Q4 (OR\u00a0=\u00a00.25, P\u00a0=\u00a00.004) groups showed significantly lower odds of cognitive impairment, with a significant trend (P\u00a0=\u00a00.003). Receiver operating characteristic (ROC) curve analysis revealed an area under the curve (AUC) of 0.65 (95% CI: 0.58\u20130.72) for 25(OH)D3 in identifying cognitive impairment. Interaction tests indicated that factors such as gender, hypertension, cerebral infarction, and fatty liver did not significantly modify the association between 25(OH)D3 and cognitive impairment (P for interaction &amp;gt; 0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study found that 25(OH)D3 levels were negatively correlated with the prevalence of cognitive impairment in middle-aged and elderly individuals with T2DM. Higher 25(OH)D3 levels are associated with lower odds of cognitive impairment, and 25(OH)D3 may have potential as a marker for cognitive impairment in this population. These findings highlight 25(OH)D3 as a potential factor of interest for further research into the prevention and intervention of cognitive impairment in middle-aged and elderly patients with T2DM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1803549","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:13:04Z","timestamp":1776399184000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Serum 25(OH)D3 level is associated with cognitive impairment in middle-aged and elderly patients with type 2 diabetes mellitus"],"prefix":"10.3389","volume":"17","author":[{"given":"Xin","family":"Wu","sequence":"first","affiliation":[{"name":"Anhui Medical University","place":["Hefei, Anhui, China"]},{"name":"Department of Endocrinology, Hefei Second People\u2019s Hospital","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Wei","sequence":"additional","affiliation":[{"name":"Anhui Medical University","place":["Hefei, Anhui, China"]},{"name":"Department of Endocrinology, Hefei Second People\u2019s Hospital","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Anhui Medical University","place":["Hefei, Anhui, China"]},{"name":"Department of Endocrinology, Hefei Second People\u2019s Hospital","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoFang","family":"Han","sequence":"additional","affiliation":[{"name":"Anhui Medical University","place":["Hefei, Anhui, China"]},{"name":"Department of Endocrinology, Hefei Second People\u2019s Hospital","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/ndt\/gfaf177","article-title":"IDF Diabetes Atlas 11th edition 2025: global prevalence and projections for 2050","volume":"41","author":"Duncan","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-020-01648-9","article-title":"The prevalence of mild cognitive impairment in type 2 diabetes mellitus patients: a systematic review and meta-analysis","volume":"58","author":"You","year":"2021","journal-title":"Acta Diabetol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30118-2","article-title":"Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities","volume":"8","author":"Srikanth","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004826","article-title":"Practice guideline update summary: Mild cognitive impairment [RETIRED]: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology","volume":"90","author":"Petersen","year":"2018","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2025.04.057","article-title":"The impact of cognitive impairment on cardiovascular disease","volume":"85","author":"Jamil","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2013.10.003","article-title":"The local production of 1,25(OH)2D3 promotes osteoblast and osteocyte maturation","author":"Turner","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-03989-w","article-title":"Tremendous fidelity of vitamin D3 in age-related neurological disorders","volume":"61","author":"Skv","year":"2024","journal-title":"Mol Neurobiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.173","article-title":"Vitamin D and risk of cognitive decline in elderly persons","volume":"170","author":"Llewellyn","year":"2010","journal-title":"Arch Intern Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/0891988711422528","article-title":"Montreal cognitive assessment in detecting cognitive impairment in Chinese elderly individuals: a population-based study","volume":"24","author":"Lu","year":"2011","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2012.03675.x","article-title":"Vitamin D insufficiency and mild cognitive impairment: cross-sectional association","volume":"19","author":"Annweiler","year":"2012","journal-title":"Eur J Neurol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1581610","article-title":"Association of serum 25(OH)D3 and cognitive levels with biological aging in the elderly: a cross-sectional study","volume":"12","author":"Li","year":"2025","journal-title":"Front Nutr"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000755","article-title":"Vitamin D and the risk of dementia and Alzheimer disease","volume":"83","author":"Littlejohns","year":"2014","journal-title":"Neurology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2017.03.003","article-title":"Associations of lower vitamin D concentrations with cognitive decline and long-term risk of dementia and Alzheimer\u2019s disease in older adults","volume":"13","author":"Feart","year":"2017","journal-title":"Alzheimers Dement"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-170407","article-title":"Vitamin D and the risk of dementia: The Rotterdam Study","volume":"60","author":"Licher","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.116.141531","article-title":"Vitamin D is not associated with incident dementia or cognitive impairment: an 18-y follow-up study in community-living old men1, 2, 3","volume":"105","author":"Olsson","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.17269\/s41997-019-00290-5","article-title":"Vitamin D status, cognitive decline and incident dementia: the Canadian Study of Health and Aging","volume":"111","author":"Duchaine","year":"2020","journal-title":"Can J Public Health"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-132612","article-title":"Vitamin D is not associated with cognitive status in a cohort of very old hospitalized patients","author":"Graf","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph120708281","article-title":"Evaluating the association between diabetes, cognitive decline and dementia","volume":"12","author":"Ojo","year":"2015","journal-title":"Int J Environ Res Public Health"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2008.05.001","article-title":"Vitamin D and neurocognitive dysfunction: Preventing \u201cD\u201decline","volume":"29","author":"Buell","year":"2008","journal-title":"Mol Aspects Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157146","article-title":"Neuroprotective roles of vitamin D: Bridging the gap between mechanisms and clinical applications in cognitive decline","volume":"26","author":"Liu","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078170","article-title":"Primary 1,25-dihydroxyvitamin D3 response of the interleukin 8 gene cluster in human monocyte- and macrophage-like cells","volume":"8","author":"Ryyn\u00e4nen","year":"2013","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.diabres.2006.10.007","article-title":"Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-dihydroxyvitamin D(3) works as anti-inflammatory","volume":"77","author":"Giulietti","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.24.10990","article-title":"Down-regulation of NF-kappa B protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3","volume":"92","author":"Yu","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"B24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11892-016-0775-x","article-title":"Diabetes and cognitive impairment","volume":"16","author":"Zilliox","year":"2016","journal-title":"Curr Diabetes Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","article-title":"Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications","volume":"14","author":"Biessels","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/nu13124358","article-title":"Vitamin D deficiency is inversely associated with homeostatic model assessment of insulin resistance","volume":"13","author":"Rafiq","year":"2021","journal-title":"Nutrients"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0143","article-title":"Brain atrophy in type 2 diabetes","volume":"36","author":"Moran","year":"2013","journal-title":"Diabetes Care"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/s0028-3908(01)00009-0","article-title":"Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture","volume":"40","author":"Ibi","year":"2001","journal-title":"Neuropharmacology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(03)00105-9","article-title":"Zinc-induced apoptosis in substantia nigra of rat brain: neuroprotection by vitamin D3","volume":"34","author":"Lin","year":"2003","journal-title":"Free Radical Biol Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1803549\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:13:06Z","timestamp":1776399186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1803549\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":29,"alternative-id":["10.3389\/fendo.2026.1803549"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1803549","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"article-number":"1803549"}}